|
⚲
|
| Keyboard |
| Mack Gene
✚
|
|
|---|---|
| CIK # | 0001737979 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001737979] | |
| 4 | [0001737979] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gain Therapeutics Inc | |
| Mack Gene | |
| SELLAS Life Sciences Group Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Gain Therapeutics Inc GANX
Employee Stock Option (right to buy) · derivative
|
2026-03-24 | Grant | 200,000 | $0.00 | |
|
Gain Therapeutics Inc GANX
Employee Stock Option (right to buy) · derivative
|
2025-03-20 | Grant | 200,000 | $0.00 | |
|
Gain Therapeutics Inc GANX
Stock Option (right to buy) · derivative
|
2025-01-06 | Grant | 271,325 | $0.00 | |
|
Gain Therapeutics Inc GANX
Common Stock
|
2024-08-09 | Buy | 14,400 | $1.01 | 14,544 |
|
Gain Therapeutics Inc GANX
Employee Stock Option (right to buy) · derivative
|
2024-04-08 | Grant | 200,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2018-04-20 | Grant | 40,000 | $0.00 |